iTonic Holdings (ITOC) Interest Expenses (2024 - 2025)
iTonic Holdings (ITOC) reported Interest Expenses of $48058.0 for Q4 2025, up 62.32% on a YoY basis from $29607.0 in Q4 2024, and up 62.32% sequentially from $29607.0 in Q4 2024.
iTonic Holdings (ITOC) Interest Expenses (2024 - 2025) Analysis & Trends
iTonic Holdings (ITOC) has 2 years of Interest Expenses data on file, last reported at $48058.0 in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses rose 62.32% year-over-year to $48058.0; the trailing twelve-month figure through Dec 2025 stood at $48058.0 (up 62.32% YoY), and the FY2025 full-year result was $48058.0, up 62.32% from the prior year.
- Interest Expenses advanced to $48058.0 in Q4 2025, from $29607.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $48058.0 in Q4 2025 to a low of $29607.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.10 Bn | 176.81 Bn | 6.27 Bn | 1.50 Bn |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 148.00 Mn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn | 142.00 Mn |
| 4 | Boston Scientific | 68.57 Bn | 67.12 Bn | 3.61 Bn | 512.00 Mn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 400.20 Mn |
| 6 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 96.00 Mn |
| 7 | Dexcom | 28.32 Bn | 27.20 Bn | 750.30 Mn | 3.10 Mn |
| 8 | Smith & Nephew | 26.94 Bn | 26.36 Bn | - | -140.00 Mn |
| 9 | Koninklijke Philips | 25.45 Bn | 22.33 Bn | 2.07 Bn | -97.17 Mn |
| 10 | iTonic Holdings | 4.33 Mn | 1.40 Mn | - | 48,058.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 48,058.00 |
| Dec 31, 2025 | 48,058.00 |
| Dec 31, 2024 | 29,607.00 |
| Dec 31, 2024 | 29,607.00 |